Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 302

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 302
---
 effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The effectiveness of the Company’s internal control over financial reporting has been audited by PricewaterhouseCoopers Audit (PCAOB ID 1347 ) and Forvis Mazars SA (PCAOB ID 1334 ) independent registered public accounting firms, as stated in their report on the Company’s internal control over financial reporting as of December 31, 2024 , which is included herein. See paragraph (c) of the present Item 15., below. c. See report of PricewaterhouseCoopers Audit and Forvis Mazars SA , independent registered public accounting firms, included under “Item 18. Financial Statements” on page 187 . d. There were no changes to our internal control over financial reporting that occurred during the period covered by this Form 20-F that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

| 180 | SANOFIFORM 20-F2024 |

| PART II                                    |
| ITEM 16A. Audit Committee Financial Expert |

Item 16A. Audit Committee Financial Expert The Audit Committee is composed of Carole Ferrand, Clotilde Delbos, Christophe Babule, Fabienne Lecorvaisier and Anne- Françoise Nesmes. Our Board of Directors has determined that all directors are independent financial experts within the meaning of Section 407 of the Sarbanes-Oxley Act of 2002. The Board of Directors deemed Carole Ferrand to be a financial expert based on her education and experience in audit at PricewaterhouseCoopers and as Chief Financial Officer of Sony France, EuropaCorp, Groupe Artémis and Capgemini. She is now Head of Strategy and Development of Motier Holding. The Board of Directors deemed Clotilde Delbos to be a financial expert based on her education and experience in Audit, Mergers & Acquisitions and Treasury, including at Price Waterhouse and Pechiney. She has also been Chief Financial Officer of Renault Group for six years. The Board of Directors deemed Christophe Babule to be a financial expert based on his education and experience in audit and corporate finance in major corporations and as Executive Vice President and Chief Financial Officer of L’Oréal. He has also served as a director of L’Oréal US Inc. The Board of Directors deemed Fab